国产精品粉嫩在线播放,国产区在线视频一区二区,青青草青青视频在线观看

常八九無二三

版主

應助: 0 (幼兒園)
金幣: 226.9
帖子: 27
在線: 3.2小時
蟲號: 6467006

已領完

投稿第一篇SCI，7月份收到編輯部回信，請問修回后中的機會大不大啊: 領取紅包 (小木蟲手機app專屬紅包)

掃一掃，下載小木蟲客戶端

意見如下

Reviewers' comments:
------------------------------------------------------
Reviewer E:

The manuscript by Wu et al. reviews the role of Gli-associated oncogenes, in
particular Gli-1, in cancer development, and as a potential target for
cancer therapy.  Gli-1 is an important oncogene and is found to be
overexpressed in a variety of cancers. The manuscript provides a good
overview of the current state of knowledge of the role of Gli-1 in mediating
signalling through the Hedgehog pathway, and how alterations in Gli-1 may
contribute to cancer development.  The manuscript also focuses on the
potential of inhibitors of Gli-1 and other components of the Hedgehog
pathway to be used in cancer therapy.  An extensive reference list is
provided, covering relevant articles in the field.

However, there are two major issues with the current manuscript which must
be corrected before it could be published.

1. The grammar requires extensive correction, as the errors detract
significantly from the meaning of the key points, and would make it
difficult for readers to fully understand the points being made in the
review.

2. In particular in the discussion of inhibitors of Gli-1 and other
components of the Hedgehog pathway, a clear distinction must be made between
effects demonstrated in cell culture, models, in xenograft experiments in
animal models, and effects in clinical trials.  This distinction is not
clear in the present manuscript, and this will lead to confusion on the part
of readers as to the current state of development of Gli-1 inhibitors for
cancer treatment. For example, resveratrol is described as a medicine
(Section 1.3), but this may be an overstatement. A more critical analysis
of the data with regard to potential Gli inhibitors is required in order for
the review to be of maximum benefit to cancer researchers.

Reviewer L:

The work titled “Glioma-associated oncogene especially Gli-1 function in
the carcinogenesis and cancer targeted therapy” is based on an interesting
area. The work can be considered for publication; however, it needs some
serious revisions before its acceptance. The manuscript must be revised as
per following comments-
1. The title looks difficult to understand, it may be revised something like
Role of glioma-associated Gli-1 oncogene in the carcinogenesis and cancer
targeted therapy.
2. Information provided in the manuscript is not adequate as I can see few
important researches like “Scientific Reports 6, Article number: 22184
(2016)”, BMC Cancer. 2009;9:298, etc. are not included.
3. Language editing is also required as few phrases are written
grammatically wrong for example, “in abstract section - Glioma-associated
oncogene (Gli) belongs…”; “in introduction - therapeutic target for
cancers…; resveratrol and cyclopamine”; “GLI-1 CLOSLY RELATED”;
“Moreover,…”; “exerts anticancer effects through”; “ITRA, an
inhibitor of Smo”, etc.
4. Delete phrase “In our review, we summarized the Gli function in the
carcinogenesis and cancer targeted therapy” from introduction section as
it is also written in the abstract.

------------------------------------------------------
Editorial comments:

This MS covers a good topic. However, there are major concerns over the
presentation and the language quality. The following should be carefully
addressed by the authors:

1. The rationale and the significance should be clearly stated in the
introduction section.
2. The abstract should be expanded to cover the major findings in the field.
3. The references should be updated.
4. A professional editing for language and style is needed. A certificate
for such an editing should be provided when resubmitting this MS.
5. The CCDT format should be followed.

-----------------------------------------------------

發(fā)自小木蟲Android客戶端

[ Last edited by 常八九無二三 on 2017-8-27 at 14:56 ]

回復此樓

» 猜你喜歡

11408 321分求調劑已經(jīng)有4人回復
301求調劑已經(jīng)有12人回復
085801 總分275 本科新能源求調劑已經(jīng)有9人回復
085600 295分求調劑已經(jīng)有17人回復
289求調劑已經(jīng)有23人回復
291求調劑已經(jīng)有23人回復
304求調劑已經(jīng)有15人回復
285求調劑已經(jīng)有11人回復
材料調劑已經(jīng)有11人回復
292分，材料與化工，申請調劑已經(jīng)有19人回復

» 搶金幣啦！回帖就可以得到:

查看全部散金貼

1樓 2017-08-27 14:40:21

已閱回復此樓關注TA 給TA發(fā)消息送TA紅花 TA的回帖

回帖支持 ( 顯示支持度最高的前 50 名 )

小川哲夢

超級版主

應助: 90 (初中生)
金幣: 7355.1
帖子: 2385
在線: 255.7小時
蟲號: 2183096

★
小木蟲: 金幣+0.5, 給個紅包，謝謝回帖

好好修改，機會還是蠻大的，最怕就是連修改的機會都沒有。

發(fā)自小木蟲IOS客戶端

贊一下(1人)

回復此樓

11樓2017-08-27 21:38:30

已閱回復此樓關注TA 給TA發(fā)消息送TA紅花 TA的回帖

國際科學編輯

超級版主

應助: 1532 (講師)
金幣: 3627.6
帖子: 7972
在線: 146.9小時
蟲號: 4407167

★
小木蟲: 金幣+0.5, 給個紅包，謝謝回帖

大修，修改后一般還要再審，認真對照意見仔細修改，還是有較大機會的，祝好運！

發(fā)自小木蟲IOS客戶端

贊一下(1人)

回復此樓

15樓2017-09-03 17:47:01

已閱回復此樓關注TA 給TA發(fā)消息送TA紅花 TA的回帖

蝦米愛蟲蟲

超級版主

應助: 0 (幼兒園)
金幣: 86.1
帖子: 144
在線: 6.3小時
蟲號: 5467352

★
liouzhan654: 金幣+1, 感謝交流 2017-08-27 15:07:57

讓修改機會就大

發(fā)自小木蟲IOS客戶端

回復此樓

9樓2017-08-27 14:52:12

已閱回復此樓關注TA 給TA發(fā)消息送TA紅花 TA的回帖

瑟可米瑟

管理員

應助: 3 (幼兒園)
金幣: 3805.5
帖子: 345
在線: 64.8小時
蟲號: 3507329

挺大啊

發(fā)自小木蟲Android客戶端

回復此樓

10樓2017-08-27 14:56:17

已閱回復此樓關注TA 給TA發(fā)消息送TA紅花 TA的回帖

caolinzk789

主管區(qū)長

★
小木蟲: 金幣+0.5, 給個紅包，謝謝回帖

本帖內容被屏蔽

14樓2017-09-02 01:43:47

已閱回復此樓關注TA 給TA發(fā)消息送TA紅花 TA的回帖

簡單回復

橘色翡冷翠2樓

2017-08-27 14:40 回復

常八九無二三(金幣+2): 謝謝參與

已獲得2個金幣發(fā)自小木蟲Android客戶端

zzjj_2073樓

2017-08-27 14:40 回復

常八九無二三(金幣+1): 謝謝參與

已獲得1個金幣發(fā)自小木蟲IOS客戶端

oil-shale4樓

2017-08-27 14:40 回復

常八九無二三(金幣+1): 謝謝參與

已獲得1個金幣發(fā)自小木蟲Android客戶端

150294815325樓

2017-08-27 14:40 回復

常八九無二三(金幣+2): 謝謝參與

已獲得2個金幣發(fā)自小木蟲Android客戶端

常清泉6樓

2017-08-27 14:40 回復

常八九無二三(金幣+1): 謝謝參與

已獲得1個金幣發(fā)自小木蟲Android客戶端

hlj格�；�7樓

2017-08-27 14:40 回復

常八九無二三(金幣+1): 謝謝參與

已獲得1個金幣發(fā)自小木蟲Android客戶端

FQ11118樓

2017-08-27 14:40 回復

常八九無二三(金幣+2): 謝謝參與

已獲得2個金幣發(fā)自小木蟲Android客戶端

逝水無痕199012樓

2017-08-27 23:12 回復

祝福發(fā)自小木蟲IOS客戶端

54061623613樓

2017-08-28 06:17 回復

祝福發(fā)自小木蟲IOS客戶端

模擬分析16樓

2017-09-03 18:32 回復

666 發(fā)自小木蟲Android客戶端

最具人氣熱帖推薦 [查看全部]	作者	回/看	最后發(fā)表

[考研] 材料調劑 +14	一樣YWY 2026-04-01	14/700	2026-04-01 21:07 by lijunpoly
[考研] 290求調劑 +5	dfffsar 2026-03-29	5/250	2026-04-01 19:45 by 6781022
[考研] 一志愿西安交大材料學碩（英一數(shù)二）347，求調劑到高分子/材料相關專業(yè) +7	zju51 2026-03-31	9/450	2026-04-01 19:35 by CFQZAFU
[考研] 【求調劑】085601材料工程專碩 \| 總分272 \| +10	腳滑的守法公民 2026-03-27	10/500	2026-04-01 17:23 by pies112
[考研] 311求調劑 +11	藍月亮亮 2026-03-30	11/550	2026-04-01 16:33 by 七度不信任
[考研] 311求調劑 +10	李芷新1 2026-03-31	10/500	2026-04-01 14:38 by chenqifeng666
[考研] 材料0856 英一數(shù)二 323 求調劑 +9	袁sy 2026-04-01	9/450	2026-04-01 14:30 by wangjy2002
[考研] 求調劑 +4	DADA怪 2026-03-31	4/200	2026-04-01 14:30 by ZXlzxl0425
[碩博家園] 考研調劑 +5	駱駝男人 2026-04-01	5/250	2026-04-01 14:28 by syjjj0321
[考研] 材料調劑 +11	一樣YWY 2026-03-31	11/550	2026-04-01 11:35 by wangjy2002
[考研] 一志愿西交大080500材料學碩349 +6	jqx1258 2026-03-31	7/350	2026-03-31 21:08 by yuq
[考研] 0856求調劑 +9	楒桉 2026-03-28	9/450	2026-03-31 19:06 by 暮澤12
[考研] 266求調劑 +3	哇呼哼呼哼 2026-03-29	3/150	2026-03-31 10:06 by cal0306
[考研] 327求調劑 +5	小卡不卡. 2026-03-29	5/250	2026-03-30 19:30 by Wang200018
[考研] 材料化工340求調劑 +3	jhx777 2026-03-30	3/150	2026-03-30 17:54 by JourneyLucky
[考研] 343求調劑 +6	愛羈絆 2026-03-29	6/300	2026-03-29 12:00 by 無際的草原
[考研] 本科新能源科學與工程，一志愿華理能動285求調劑 +7	AZMK 2026-03-28	11/550	2026-03-28 21:01 by xxxsssccc
[考研] 一志愿上海理工能源動力（085800）310分求調劑 +3	zhangmingc 2026-03-27	4/200	2026-03-27 19:01 by 給你你注意休息
[考研] 復試調劑，一志愿南農083200食品科學與工程 +5	XQTJZ 2026-03-26	5/250	2026-03-27 14:49 by 狂炫麥當當
[考研] 調劑 +3	李嘉圖·S·路 2026-03-27	3/150	2026-03-27 11:19 by wangjy2002